The usefulness of angiotensin-(1-7) and des-Arg⁹-bradykinin as novel biomarkers for metabolic syndrome

Hypertens Res. 2021 Aug;44(8):1034-1036. doi: 10.1038/s41440-021-00671-9. Epub 2021 May 27.

Authors

Akira Sugawara¹, Hiroki Shimada^{2

3}, Yuri Otsubo², Takumi Kouketsu², Susumu Suzuki², Atsushi Yokoyama²

Affiliations

¹ Department of Molecular Endocrinology, Tohoku University Graduate School of Medicine, Sendai, Japan. akiras2i@med.tohoku.ac.jp.
² Department of Molecular Endocrinology, Tohoku University Graduate School of Medicine, Sendai, Japan.
³ Division of Pathology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan.

PMID: 34045691
DOI: 10.1038/s41440-021-00671-9

No abstract available

Publication types

Editorial

MeSH terms

Angiotensin I
Biomarkers
Bradykinin / analogs & derivatives
Humans
Metabolic Syndrome* / diagnosis
Peptide Fragments

Substances

Biomarkers
Peptide Fragments
bradykinin, des-Arg(9)-
Angiotensin I
angiotensin I (1-7)
Bradykinin